We need more educational or clinical projects that have a real-world impact on reducing disparities in dermatology, said Art Papier, MD, dermatologist, CEO, VisualDx.
Art Papier, MD, dermatologist, CEO, VisualDx, talks about disparity prevention in dermatology, including the second year of Project IMPACT, and considerations in artificial intelligence (AI) and machine learning.
Transcript
What are your goals for the second year of Project IMPACT?
I think we really want to see specific projects that are either educational or clinical that have real-world impact. Project IMPACT, the name, we chose that really because we want to be substantial. We don't want to just be performative and be just discussing an issue. We want to see some results. In the second year, we want to see more people involved and we want to see specific projects, and we're hoping to do specific projects around medical education.
How can we ensure future projects are including underserved populations in their research?
I think there's tremendous interest in primary care. So, in rural areas or inner city areas where you have federally qualified health clinics serving the underserved, there's a real need to bring the kind of information that those health care professionals can use in real time. In my work, I've been thinking about this problem, "What's the right information for the right patient population?" So we're thinking about, if the clinic is urban, what do they need? If the clinic's rural, what's the patient population? How do we really bring customized information to each population?
Since dermatological conditions can appear differently depending on skin type, what steps should be taken in AI development?
People are beginning to understand that AI and machine learning are totally dependent on good quality data. It's garbage in, garbage out. You have to have good data, and if you train your algorithms just on white skin, it's not going to work on brown skin.
So in our work at VisualDx, as an example, we've been collecting imagery for over 20 years, and since the start of our efforts, it's always been equitable. We have something like 32% of the imagery in the system is in brown skin, and we have tags on that imagery so that when we train our AI, it's equitable. This is key to having equity in AI and machine learning—it's the data you train on and how precise the data is.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Managing Skin Conditions: Highlighting Ruxolitinib Cream, Phototherapy Efficacy and Cost
April 8th 2025Research presented at the 2025 Academy of Managed Care Pharmacy annual meeting analyzed real-world treatment outcomes for dermatologic conditions, specifically highlighting the efficacy of ruxolitinib cream for atopic dermatitis and the potential for phototherapy to delay costly biologic initiation.
Read More
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More